Big Endothelin-1 (1 – 31) (Human)

Big Endothelin-1 (1 – 31) (Human)

0.1 mg
€198,00

You can create a Quote after adding product to the Cart.

Skip to product information
Big Endothelin-1 (1 – 31) (Human)

Big Endothelin-1 (1 – 31) (Human)

Product ID: 4360

Cys – Ser – Cys – Ser – Ser – Leu – Met – Asp – Lys – Glu – Cys – Val – Tyr – Phe – Cys – His – Leu – Asp – Ile – Ile – Trp – Val – Asn – Thr – Pro – Glu – His – Val – Val – Pro – Tyr

€198,00
excl. 19% VAT
Quantity
Description

Big ET-1 (1-31) (human, bovine)

M.W. 3628.2

C162H236N38O47S5

133972-52-8

Cys – Ser – Cys – Ser – Ser – Leu – Met – Asp – Lys – Glu – Cys – Val – Tyr – Phe – Cys – His – Leu – Asp – Ile – Ile – Trp – Val – Asn – Thr – Pro – Glu – His – Val – Val – Pro – Tyr

Big Endothelin-1 (1-31) is an endogenous form of Endothelin-1. The 31 mer oligopeptide is generated by chymase hydolysation from its precursor. This conversation process can be blocked with Phosphoramidon, which is a potent endothelin-converting-enzyme inhibitor. The conversation from Big Endothelin-1 (1-31) into Endothelin 1 will not be effected.The biological activity of Big Endothelin-1 (1 – 31) is examined by the Division of Pharmacology, Peptide Institute, Inc.

Synthetic Product (disulfide bonds between Cys1-Cys15 and Cys3-Cys11)

The purity is guaranteed to be higher than 99% by HPLC

References:

1. A. Nakano, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido, J. Immunol, 159, 1987 (1997) (Original; New Endogenous Form) 2. F. Kishi, K. Minami, N. Okishima, M. Murakami, S. Mori, M. Yano, Y. Niwa, Y. Nakaya, and H. Kido, Biochem. Biophys. Res. Commun., 248, 387 (1998) (Pharmacol.) 3. M. Yoshizumi, D. Inui, N. Okishima, H. Houchi, K. Tsuchiya, H. Wakabayashi, H. Kido, and T. Tamaki, Eur. J. Pharmacol., 348, 305 (1998) (Pharmacol.) 4. M. Yoshizumi, S. Kim, S. Kagami, A. Hamaguchi, K. Tsuchiya, H. Houchi, H. Iwao, H. Kido, and T. Tamaki, Br. J. Pharmacol., 125, 1019 (1998) (Pharmacol.)

You may also like